
Management of Myasthenia Gravis (September 2021 Neurology Recall)
Neurology® Podcast
00:00
Is the Cost of the Drug a Factor?
The cost of the drug or the frequency of the infusions? Did that factor into the discussions at all? It actually did. One of the things we said was that the roll of this drug and the place in the treatment algorothem will continue to evolve. We do need some cost data and cost benefit now, we are aware that, you know, true cost benefit or cost effectiveness analysis is very unlikely to happen.
Transcript
Play full episode